Imago BioSciences IPO

Imago BioSciences discovers and develops novel therapeutics for the treatment of hematologic disorders targeting epigenetic enzymes.

Register for Details

For more details on financing and valuation for Imago BioSciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Imago BioSciences's ticker symbol?


What is Imago BioSciences's stock price?

36.01 as of 1/10/23

Learn more about Imago BioSciences

Forge green plus iconForge green minus icon

When was Imago BioSciences founded?

Imago BioSciences was founded in 2012.
Updated on: Jun 12, 2022